Literature DB >> 23744648

The secretome signature of colon cancer cell lines.

Esther Imperlini1, Irene Colavita, Marianna Caterino, Peppino Mirabelli, Daniela Pagnozzi, Luigi Del Vecchio, Rosa Di Noto, Margherita Ruoppolo, Stefania Orrù.   

Abstract

The definition of the secretome signature of a cancer cell line can be considered a potential tool to investigate tumor aggressiveness and a preclinical exploratory study required to optimize the search of cancer biomarkers. Dealing with a cell-specific secretome limits the contamination by the major components of the human serum and reduces the range of dynamic concentrations among the secreted proteins, thus favouring under-represented tissue-specific species. The aim of the present study is to characterize the secretome of two human colon carcinoma cell lines, CaCo-2 and HCT-GEO, in order to evaluate differences and similarities of two colorectal cancer model systems. In this study, we identified more than 170 protein species, 64 more expressed in the secretome of CaCo-2 cells and 54 more expressed in the secretome of HCT-GEO cells; 58 proteins were shared by the two systems. Among them, more than 50% were deemed to be secretory according to their Gene Ontology annotation and/or to their SignalP or SecretomeP scores. Such a characterization allowed corroborating the potential of a cell culture-based model in order to describe the cell-specific invasive properties and to provide a list of putative cancer biomarkers.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CACO-2; COLON CANCER; HCT-GEO; PROTEOMICS; SECRETOME

Mesh:

Year:  2013        PMID: 23744648     DOI: 10.1002/jcb.24600

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA.

Authors:  Francesca Maria Orlandella; Raffaela Mariarosaria Mariniello; Paola Lucia Chiara Iervolino; Esther Imperlini; Annalisa Mandola; Anna Verde; Anna Elisa De Stefano; Katia Pane; Monica Franzese; Silvia Esposito; Fulvio Basolo; Stefania Orrù; Giuliana Salvatore
Journal:  Endocrine       Date:  2019-03-29       Impact factor: 3.633

2.  Differentially expressed and activated proteins associated with non small cell lung cancer tissues.

Authors:  E Nigro; E Imperlini; O Scudiero; M L Monaco; R Polito; G Mazzarella; S Orrù; A Bianco; A Daniele
Journal:  Respir Res       Date:  2015-06-24

Review 3.  Levels of soluble E-cadherin in breast, gastric, and colorectal cancers.

Authors:  Ombretta Repetto; Paolo De Paoli; Valli De Re; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

4.  Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response.

Authors:  Luisa Matos do Canto; Sarah Santiloni Cury; Mateus Camargo Barros-Filho; Bruna Elisa Catin Kupper; Maria Dirlei Ferreira de Souza Begnami; Cristovam Scapulatempo-Neto; Robson Francisco Carvalho; Fabio Albuquerque Marchi; Dorte Aalund Olsen; Jonna Skov Madsen; Birgitte Mayland Havelund; Samuel Aguiar; Silvia Regina Rogatto
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.379

5.  Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.

Authors:  Faryal Mehwish Awan; Anam Naz; Ayesha Obaid; Amjad Ali; Jamil Ahmad; Sadia Anjum; Hussnain Ahmed Janjua
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

6.  Data from a proteomic analysis of colonic fibroblasts secretomes.

Authors:  Sun-Xia Chen; Xiao-En Xu; Xiao-Qing Wang; Shu-Jian Cui; Lei-Lei Xu; Ying-Hua Jiang; Yang Zhang; Hai-Bo Yan; Qian Zhang; Jie Qiao; Peng-Yuan Yang; Feng Liu
Journal:  Data Brief       Date:  2014-08-21

7.  Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model.

Authors:  Esther Imperlini; Stefania Orrù; Claudia Corbo; Aurora Daniele; Francesco Salvatore
Journal:  J Neurochem       Date:  2014-03-24       Impact factor: 5.372

8.  Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.

Authors:  Jie Qiao; Cai-Yun Fang; Sun-Xia Chen; Xiao-Qing Wang; Shu-Jian Cui; Xiao-Hui Liu; Ying-Hua Jiang; Jie Wang; Yang Zhang; Peng-Yuan Yang; Feng Liu
Journal:  Oncotarget       Date:  2015-10-06

Review 9.  Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer.

Authors:  Armando Cevenini; Stefania Orrù; Esther Imperlini
Journal:  Medicina (Kaunas)       Date:  2020-08-31       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.